There are 594 resources available
407P - Dissecting clinicopathologic features and treatment response in patients with LKB1-inactive NSCLC
Presenter: Giorgia Di Liberti
Session: Poster Display session
408P - Real-life experience of rare hepatoid adenocarcinomas of the lung: A large retrospective french cohort
Presenter: Thomas Favé
Session: Poster Display session
409P - IMpower010: Digital pathology (DP) vs manual SP263 PD-L1 tumour cell (TC) scoring on whole imaging slides from patients (pts) with stage II-IIIA PD-L1 TC =50% NSCLC
Presenter: Martin Reck
Session: Poster Display session
410P - Cetuximab enhances cytotoxicity of fulzerasib and sotorasib in KRAS-mutant lung cancer
Presenter: Daniel Olmo González
Session: Poster Display session
411P - Tumor miRNAs in small-extracellular vesicles dampen the CD8+ T cell response against tumor and predict response to immunotherapy in NSCLC
Presenter: Elvire Pons-Tostivint
Session: Poster Display session
412P - Re-GraDE NSCLC: First real-world data on the daily practice of pathologic response assessment following Immune oncologic combination therapies in NSCLC in Germany
Presenter: Felix Elsner
Session: Poster Display session
Classifying Multiple Lung Cancers by Spatial Microenvironment: Tertiary Lymphoid Structures at Interface Zone as Immune Hubs and Prognostic Determinants
Presenter: Xiaoqiu Yuan
Session: Poster Display session
414P - Exosome whisperers: Decoding SPHK1’s role in cisplatininduced immune escape of NSCLC
Presenter: Huan Gao
Session: Poster Display session
Resources:
Abstract
415P - Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 =50%: Insights from the pembrolizumab 5-year global registry
Presenter: Alessio Cortellini
Session: Poster Display session
416P - Application of artificial intelligence: Machine learning for survival prediction in non-small cell lung cancer with brain metastases
Presenter: Julia Giner
Session: Poster Display session